The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
Leen NA, de Weijer AD, van Rooij SJH, Kennis M, Baas JMP, Geuze E. · Chronic stress (Thousand Oaks, Calif.) · 2022 · Longitudinal biomarker cohort
Original publication · Original publication · Original publication
Recorded summary
Plasma anandamide and 2-AG were measured in 54 veterans with PTSD and 26 combat controls. Pretreatment levels did not predict symptom reduction following trauma-focused therapy; cortisol decreased over time.
Recorded limitations
Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
Evidence and provenance
Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.
Study design and assessment
- design
- Longitudinal biomarker cohort
- assessment
- category
- observational
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- reviewed At
- 2026-10-23
- trust Factor
- score
- 1
- scope
- Paper
- status
- assessed
- randomized Controlled Trial
- Not recorded
- blinding
- not-confirmed
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- review Scope
- Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
- assessed At
- 2026-10-27
- jadad
- status
- unassessed
- score
- Not recorded
- evidence
- evidence Type
- Molecular biomarkers
- measured Genes
- None recorded
- relationship Note
- Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
Topics and recorded topic scores
- key
- vision:biomarkers
- title
- EMDR, cortisol and molecular biomarkers
- collection
- vision
- trust Score
- 1
Citation snapshot and identifiers
- id
- pmid-35707677
- doi
- 10.1177/24705470221107290
- pmid
- 35707677
- citation Snapshot
- count
- 17
- source
- Crossref
- retrieved At
- 2026-10-23
- citations By Collection
- vision
- 17
Complete approved library record
- id
- pmid-35707677
- publication Key
- doi:10.1177/24705470221107290
- aliases
- None recorded
- title
- The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
- journal
- Chronic stress (Thousand Oaks, Calif.)
- neurotransmitters
- None recorded
- year
- 2022
- authors
- Leen NA, de Weijer AD, van Rooij SJH, Kennis M, Baas JMP, Geuze E.
- design
- Longitudinal biomarker cohort
- kind
- Journal article
- identity Conflict
- Not recorded
- doi
- 10.1177/24705470221107290
- pmid
- 35707677
- urls
https://pmc.ncbi.nlm.nih.gov/articles/PMC9190205/ · https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- collections
vision
- categories
Molecular biomarkers · Clinical & self-report
- targets
- None recorded
- priority
- 1
- quotes
- None recorded
- summary
- Plasma anandamide and 2-AG were measured in 54 veterans with PTSD and 26 combat controls. Pretreatment levels did not predict symptom reduction following trauma-focused therapy; cortisol decreased over time.
- limitation
- Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
- citation Count
- 17
- citation Snapshot
- count
- 17
- source
- Crossref
- retrieved At
- 2026-10-23
- study Design Assessment
- category
- observational
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- reviewed At
- 2026-10-23
- paper Trust Assessment
- score
- 1
- scope
- Paper
- status
- assessed
- randomized Controlled Trial
- Not recorded
- blinding
- not-confirmed
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- review Scope
- Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
- assessed At
- 2026-10-27
- citations By Collection
- vision
- 17
- topics
- key
- vision:biomarkers
- title
- EMDR, cortisol and molecular biomarkers
- collection
- vision
- trust Score
- 1
- journal Key
- chronicstress
- journal Label
- Chronic stress (Thousand Oaks, Calif.)
- chapter Entries
- title
- The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
- journal
- Chronic stress (Thousand Oaks, Calif.)
- year
- 2022
- authors
- Leen NA, de Weijer AD, van Rooij SJH, Kennis M, Baas JMP, Geuze E.
- design
- Longitudinal biomarker cohort
- urls
https://pmc.ncbi.nlm.nih.gov/articles/PMC9190205/ · https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- doi
- 10.1177/24705470221107290
- pmid
- 35707677
- targets
- None recorded
- categories
Molecular biomarkers · Clinical & self-report
- citation Count
- 17
- citation Snapshot
- count
- 17
- source
- Crossref
- retrieved At
- 2026-10-23
- study Design Assessment
- category
- observational
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- reviewed At
- 2026-10-23
- evidence
- evidence Type
- Molecular biomarkers
- measured Genes
- None recorded
- relationship Note
- Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
- record Id
- pmid-35707677
- quotes
- None recorded
- source Pages
- None recorded
- summary
- Plasma anandamide and 2-AG were measured in 54 veterans with PTSD and 26 combat controls. Pretreatment levels did not predict symptom reduction following trauma-focused therapy; cortisol decreased over time.
- limitation
- Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
- id
- vision-biomarkers-pmid-35707677
- paper Trust Assessment
- score
- 1
- scope
- Paper
- status
- assessed
- randomized Controlled Trial
- Not recorded
- blinding
- not-confirmed
- peer Reviewed
- true
- basis
- Molecular or biomarker analysis with combined trauma-focused treatment exposure. No independently verified single- or double-blind randomized molecular comparison is assigned.
- sources
https://pubmed.ncbi.nlm.nih.gov/35707677/ · https://doi.org/10.1177/24705470221107290
- review Scope
- Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
- assessed At
- 2026-10-27
- publication Key
- doi:10.1177/24705470221107290
- collection
- vision
- chapter Number
- 4
- topic Id
- biomarkers
- topic Title
- EMDR, cortisol and molecular biomarkers
- trust Score
- 1
- evidence
- evidence Type
- Molecular biomarkers
- measured Genes
- None recorded
- relationship Note
- Treatments included CBT with exposure or EMDR. Exploratory correlations require replication; endocannabinoid concentrations are distinct from gene expression.
- jadad
- status
- unassessed
- score
- Not recorded
- condition Evidence
- id
- ptsd
- evidence
- field
- title
- text
- The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
- matched Text
- PTSD
- conditions
ptsd
- topic Trust Scores
1
- full Text
- status
- not-indexed
- retrieval Available
- false